Review of Linagliptin for the Treatment of Type 2 Diabetes Mellitus

Journal article

Peer reviewed

Joshua J NEUMILLER and Stephen M SETTER

Clinical therapeutics, Vol.34(5), pp.993-1005

2012

Handle:

https://hdl.handle.net/2376/110886

PMID: 22440191

Abstract

Diabetes. Impaired glucose tolerance

Pharmacology. Drug treatments

Biological and medical sciences

Endocrinopathies

Etiopathogenesis. Screening. Investigations. Target tissue resistance

Medical sciences

Endocrine pancreas. Apud cells (diseases)

6 Record Views

Title: Review of Linagliptin for the Treatment of Type 2 Diabetes Mellitus
Creators: Joshua J NEUMILLER - Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington, United States
Stephen M SETTER - Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington, United States
Publication Details: Clinical therapeutics, Vol.34(5), pp.993-1005
Academic Unit: Pharmacotherapy, Department of
Publisher: Elsevier; Bridgewater, NJ
Identifiers: 99900547167601842
Language: English
Resource Type: Journal article